Dr. Lester E. Mertz, MD

Dr. Mertz practices at Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona.

Dr. Mertz's NPI, 1083696751, was assigned on November 17, 2005. Dr. Mertz graduated from Medical College Of Wisconsin in 1981. Dr. Mertz holds Arizona license 16708.

Dr. Mertz's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale, at 13400 East Shea Boulevard, Scottsdale, AZ 85259. The practice phone is (480) 342-4201.

Dr. Mertz's primary practice is Mayo Clinic Ambulatory Surgery Center - Scottsdale in Scottsdale, Arizona. Dr. Mertz is also affiliated with Mayo Clinic Hospital - Phoenix. The medical group on file is Mayo Clinic Arizona. Dr. Mertz's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mertz practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Mertz's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Mertz is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mertz's licenses on file in 3 states: Arizona, Minnesota and Wisconsin.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, lupus, muscle disease, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Mertz treats.

CMS data shows 458 Medicare services from Dr. Mertz across 4 procedure codes in 2024, for 354 Medicare patients. Medicare paid $48,737 for them. Every service was in an office.

CMS counts 354 Medicare patients who saw Dr. Mertz in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mertz's median patient age at 68, with 65% women.

In 2024, Dr. Mertz wrote 598 Medicare Part D claims for 147 patients. 82% of them were for generic drugs. CMS names the drug for 418 of them, across 12 drugs with 11 or more claims each, at $253,332 in total drug cost. In 2023, CMS named 425 claims across 12 drugs.

Dr. Mertz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mertz as offering telehealth.

Dmand AI links 12 papers to Dr. Mertz, published from 2007 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Immunosuppressive Agents, Arizona and Biopsy. Dr. Mertz's most frequent co-authors are Andy Abril, MD, Shabana F. Pasha, MD and Kenneth J. Warrington, MD.

CMS Open Payments shows 10 general payments to Dr. Mertz from 2 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 96% of the total. Genentech, Inc. paid the most, $7,912. It also lists 1 research payment totaling $4,847 in 2020.

Dmand AI lists 4 awards for Dr. Mertz, most recently Regional Top Doctor in 2014.

Dr. Mertz graduated from Medical College Of Wisconsin in 1981. Dr. Mertz is a member of ACR.

Dr. Mertz is in network with 3 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.